Figure 2
From: Decreased miR-106a inhibits glioma cell glucose uptake and proliferation by targeting SLC2A3 in GBM
SLC2A3 is a target gene of miR-106a. (A) A schematic representation showing the putative target site for miR-106a in SLC2A3 mRNA 3′UTR. (B) Cells were transfected with miR-106a, and the expression of SLC2A3 was analyzed by Western blot. The expression of GAPDH was used as a loading control. (C) Luciferase constructs were transfected into cells transduced with miR-106a. Luciferase activity was determined 48 h after transfection. The ratio of normalized sensor to control luciferase activity is shown.